Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). YES S NO o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES o NO S
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date.
2
ASSETS
Current assets:
Property and equipment, net
LIABILITIES, MINORITY INTEREST AND STOCKHOLDERS EQUITY
Current liabilities:
Other liabilities
Commitments and contingencies
Stockholders equity:
3
Net revenue
Gross profit
Operating expenses:
Total operating expenses
Operating income (loss)
Income (loss) before provision for (benefit from) income taxes and minority interest
Net income (loss)
Net income (loss) per share:
4
OPERATING ACTIVITIES
Net cash provided by (used in) operating activities
INVESTING ACTIVITIES
Net cash used in investing activities
FINANCING ACTIVITIES
Net cash provided by (used in) financing activities
Effect of foreign exchange on cash and cash equivalents
Ending cash, cash equivalents and short-term investments
Supplemental cash flow information:
Non-cash investing activities:
5
6
Net income (loss):
7
8
9
10
11
Consolidated Net Worth (in millions)
12
13
14
15
16
Three months ended September 30, 2005
Three months ended September 30, 2004
Six months ended September 30, 2005
Six months ended September 30, 2004
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
We have a shelf registration statement on Form S-3 on file with the Securities and Exchange Commission. This shelf registration statement, which includes a base prospectus, allows us at any time to offer any combination of securities described in the prospectus in one or more offerings up to a total amount of $2.0 billion. Unless otherwise specified in a prospectus supplement accompanying the base prospectus, we will use the net proceeds from the sale of any securities offered pursuant to the shelf registration statement for general corporate purposes, including for working capital, financing capital expenditures, research and development, marketing and distribution efforts and, if opportunities arise, for acquisitions or strategic alliances. Pending such uses, we may invest the net proceeds in interest-bearing securities. In addition, we may conduct concurrent or other financings at any time.
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56